Baldwin Healthcare & Rehab Center, Llc in Baldwin City, KS

Baldwin Healthcare & Rehab Center, Llc is a medicare and medicaid certified nursing home in Baldwin City, Kansas. It is located in Douglas county at 1223 Orchard Lane, Baldwin City, Kansas 66006. You can reach out to the office of Baldwin Healthcare & Rehab Center, Llc via phone at (785) 594-6492. This skilled nursing facility has 60 federally certified beds with average occupancy rate of 81.83%. Its legal business name is Recover-care Baldwin City Llc and has the following ownership type - For Profit - Corporation.

Baldwin Healthcare & Rehab Center, Llc (Medicare CCN 175338) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in both medicare and medicaid program. This means if you are part of medicare or medicaid program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 1995 (29 years certified) and the last quality survey was conducted in October, 2019.

Name	Baldwin Healthcare & Rehab Center, Llc
Location	1223 Orchard Lane, Baldwin City, Kansas
Certified By	Medicare and Medicaid
No. of Certified Beds	60
Occupancy Rate	81.83%
Medicare ID (CCN)	175338
Legal Business Name	Recover-care Baldwin City Llc
Ownership Type	For Profit - Corporation

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with Baldwin Healthcare & Rehab Center, Llc from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1881665420
Organization Name	BALDWIN HEALTHCARE AND REHABILITATION CENTER, LLC
Doing Business As	BALDWIN HEALTHCARE AND REHABILITATION CENTER
Address	1223 Orchard Lane, Baldwin City, KS 66006
Phone Number	785-594-6492

News Archive

The Institute of Cancer Research, CRT and Astex to discover and develop novel drug candidates

Astex Pharmaceuticals, Inc, a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, Cancer Research Technology Limited (CRT) and The Institute of Cancer Research, London, have initiated a collaboration to discover and develop drug candidates targeting an undisclosed epigenetic target in a blood cancer with high unmet medical need.

Synthetic gene reveals potential therapeutic target for rare, inherited disease

DNA Repair is essential for a healthy organism. In every day of our lives, tens of thousands of damages occur in the genetic material of our cells. Hence, it is not surprising that a broad variety of repair mechanisms developed in the course of evolution that enables cells to quickly react and patch up the affected DNA strands.

Brivaracetam drug shows no added benefit for epilepsy

Brivaracetam (trade name: Briviact) has been approved since January 2016 as add-on therapy for adolescents from the age of 16 years and adults with epileptic seizures. The German Institute for Quality and Efficiency in Health Care now examined in an early benefit assessment whether this drug offers an added benefit for patients in comparison with the appropriate comparator therapy.

Stem cell-derived neurons used to regenerate lost tissue in damaged corticospinal tracts of rats

Writing in the March 28, 2016 issue of Nature Medicine, researchers at University of California, San Diego School of Medicine and Veterans Affairs San Diego Healthcare System, with colleagues in Japan and Wisconsin, report that they have successfully directed stem cell-derived neurons to regenerate lost tissue in damaged corticospinal tracts of rats, resulting in functional benefit.

Read more Medical News

› Verified 2 days ago

NPI Number	1922541788
Organization Name	RECOVER-CARE BALDWIN CITY LLC
Address	1223 Orchard Ln, Baldwin City, KS 66006
Phone Number	785-594-6492

News Archive

The Institute of Cancer Research, CRT and Astex to discover and develop novel drug candidates

Astex Pharmaceuticals, Inc, a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, Cancer Research Technology Limited (CRT) and The Institute of Cancer Research, London, have initiated a collaboration to discover and develop drug candidates targeting an undisclosed epigenetic target in a blood cancer with high unmet medical need.

Synthetic gene reveals potential therapeutic target for rare, inherited disease

DNA Repair is essential for a healthy organism. In every day of our lives, tens of thousands of damages occur in the genetic material of our cells. Hence, it is not surprising that a broad variety of repair mechanisms developed in the course of evolution that enables cells to quickly react and patch up the affected DNA strands.

Brivaracetam drug shows no added benefit for epilepsy

Brivaracetam (trade name: Briviact) has been approved since January 2016 as add-on therapy for adolescents from the age of 16 years and adults with epileptic seizures. The German Institute for Quality and Efficiency in Health Care now examined in an early benefit assessment whether this drug offers an added benefit for patients in comparison with the appropriate comparator therapy.

Stem cell-derived neurons used to regenerate lost tissue in damaged corticospinal tracts of rats

Writing in the March 28, 2016 issue of Nature Medicine, researchers at University of California, San Diego School of Medicine and Veterans Affairs San Diego Healthcare System, with colleagues in Japan and Wisconsin, report that they have successfully directed stem cell-derived neurons to regenerate lost tissue in damaged corticospinal tracts of rats, resulting in functional benefit.

Read more Medical News

› Verified 2 days ago

Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for Baldwin Healthcare & Rehab Center, Llc are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care Baldwin Healthcare & Rehab Center, Llc give to their patients.

Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

The Institute of Cancer Research, CRT and Astex to discover and develop novel drug candidates

Astex Pharmaceuticals, Inc, a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, Cancer Research Technology Limited (CRT) and The Institute of Cancer Research, London, have initiated a collaboration to discover and develop drug candidates targeting an undisclosed epigenetic target in a blood cancer with high unmet medical need.

Synthetic gene reveals potential therapeutic target for rare, inherited disease

DNA Repair is essential for a healthy organism. In every day of our lives, tens of thousands of damages occur in the genetic material of our cells. Hence, it is not surprising that a broad variety of repair mechanisms developed in the course of evolution that enables cells to quickly react and patch up the affected DNA strands.

Brivaracetam drug shows no added benefit for epilepsy

Brivaracetam (trade name: Briviact) has been approved since January 2016 as add-on therapy for adolescents from the age of 16 years and adults with epileptic seizures. The German Institute for Quality and Efficiency in Health Care now examined in an early benefit assessment whether this drug offers an added benefit for patients in comparison with the appropriate comparator therapy.

Stem cell-derived neurons used to regenerate lost tissue in damaged corticospinal tracts of rats

Writing in the March 28, 2016 issue of Nature Medicine, researchers at University of California, San Diego School of Medicine and Veterans Affairs San Diego Healthcare System, with colleagues in Japan and Wisconsin, report that they have successfully directed stem cell-derived neurons to regenerate lost tissue in damaged corticospinal tracts of rats, resulting in functional benefit.

Read more Medical News

› Verified 2 days ago

Number of Facility Reported Incidents	0
Number of Substantiated Complaints	0
Number of Fines	0
Total Amount of Fines in Dollars	$0
Number of Payment Denials	0
Total Number of Penalties	0

The resident survey data of Baldwin Healthcare & Rehab Center, Llc is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience Measure	Provider	National Avg.
Percentage of long-stay residents whose need for help with daily activities has increased	20.81	14.46
Percentage of long-stay residents who lose too much weight	2.13	5.51
Percentage of low risk long-stay residents who lose control of their bowels or bladder	32.39	48.41
Percentage of long-stay residents with a catheter inserted and left in their bladder	0.54	1.79
Percentage of long-stay residents with a urinary tract infection	1.86	2.65
Percentage of long-stay residents who have depressive symptoms	10.26	5.05
Percentage of long-stay residents who were physically restrained	0	0.23
Percentage of long-stay residents experiencing one or more falls with major injury	2.37	3.36
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine	100	93.87
Percentage of long-stay residents who received an antipsychotic medication	13.38	14.2
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine	99.43	83.88
Percentage of short-stay residents who newly received an antipsychotic medication	0	1.79
Percentage of long-stay residents whose ability to move independently worsened	15.98	17.09
Percentage of long-stay residents who received an antianxiety or hypnotic medication	15.44	19.7
Percentage of high risk long-stay residents with pressure ulcers	14.41	7.32
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine	100	95.98
Percentage of short-stay residents who made improvements in function	82.56	67.99
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine	100	82.93

Nursing Homes in Baldwin City, KS

Baldwin Healthcare & Rehab Center, Llc Location: 1223 Orchard Lane, Baldwin City, Kansas 66006 Phone: (785) 594-6492

Nursing Home

A nursing home (also called skilled nursing facility) is a facility or distinct part of an institution whose primary function is to provide medical, continuous nursing, and other health and social services to patients who are not in an acute phase of illness requiring services in a hospital, but who require primary restorative or skilled nursing services on an inpatient basis above the level of intermediate or custodial care in order to reach a degree of body functioning to permit self care in essential daily living.

A skilled nursing facility (SNF) may be a freestanding facility or part of a hospital that has been certified by Medicare to admit patients requiring subacute care and rehabilitation.

Nursing Home Compare

Nursing Home Compare allows consumers to compare information about nursing homes. It contains quality of care and staffing information for all 15,000 plus Medicare- and Medicaid-participating nursing homes.

Note: Nursing homes aren't included on Nursing Home Compare if they aren't Medicare or Medicaid certified. These Nursing Homes can be licensed by the state.

Information on Nursing Home Compare isn't an endorsement or advertisement for any nursing home and should be considered carefully. Use it with other information you gather about nursing homes facilities. Talk to your doctor or other health care provider about the information on Nursing Home Compare.